These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2509407)

  • 1. Isolation of azomycin from Pseudomonas fluorescens.
    Shoji JH; Hinoo H; Terui Y; Kikuchi J; Hattori T; Ishii K; Matsumoto K; Yoshida T
    J Antibiot (Tokyo); 1989 Oct; 42(10):1513-4. PubMed ID: 2509407
    [No Abstract]   [Full Text] [Related]  

  • 2. EM5519, a new broad-spectrum antibiotic produced by Pseudomonas fluorescens.
    Meyers E; Cooper R; Trejo WH; Georgopapadakou N; Sykes RB
    J Antibiot (Tokyo); 1983 Feb; 36(2):190-3. PubMed ID: 6403499
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens.
    Fuller AT; Mellows G; Woolford M; Banks GT; Barrow KD; Chain EB
    Nature; 1971 Dec; 234(5329):416-7. PubMed ID: 5003547
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluviols, bicyclic nitrogen-rich antibiotics produced by Pseudomonas fluorescens.
    Smirnov VV; Kiprianova EA; Garagulya AD; Esipov SE; Dovjenko SA
    FEMS Microbiol Lett; 1997 Aug; 153(2):357-61. PubMed ID: 9271863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomonas fluorescens, a producer of antibiotic substances].
    Kiprianova EA; Smirnov VV
    Antibiotiki; 1981 Feb; 26(2):135-43. PubMed ID: 6782949
    [No Abstract]   [Full Text] [Related]  

  • 6. Obafluorin, a novel beta-lactone produced by Pseudomonas fluorescens. Taxonomy, fermentation and biological properties.
    Wells JS; Trejo WH; Principe PA; Sykes RB
    J Antibiot (Tokyo); 1984 Jul; 37(7):802-3. PubMed ID: 6432765
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure of the pseudomonad fungal antibiotic phenazine-1-carboxylic acid.
    Jones GP; Lewis DG; Tate ME; Snow MR; Tiekink ER
    Acta Crystallogr C; 1988 Dec; 44 ( Pt 12)():2220-2. PubMed ID: 3152061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and sensitive determination of nitroimidazole residues in honey using stir bar sorptive extraction with mixed mode monolith followed by liquid chromatography.
    Huang X; Lin J; Yuan D
    J Sep Sci; 2011 Aug; 34(16-17):2138-44. PubMed ID: 21394912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonic acid. Part 1. The structure of pseudomonic acid A, a novel antibiotic produced by Pseudomonas fluorescens.
    Chain EB; Mellows G
    J Chem Soc Perkin 1; 1977; (3):294-309. PubMed ID: 402371
    [No Abstract]   [Full Text] [Related]  

  • 10. The chemistry of aminoglycoside antibiotics from Pseudomonas flurescence. I. Isolation, characterization and partial structure of P-2563(P) (sorbistin A1) and P-2563(A) (sorbistin B).
    Nara K; Sumino Y; Katamoto K; Akiyma S; Asai M
    Chem Pharm Bull (Tokyo); 1978 Apr; 26(4):1075-82. PubMed ID: 418887
    [No Abstract]   [Full Text] [Related]  

  • 11. B-1008, a new antibiotic of bacterial origin containing a spermidine moiety. Production, isolation, characterization and biological properties.
    Kido Y; Harada T; Yoshida T; Umemoto J; Motoki Y
    J Antibiot (Tokyo); 1980 Aug; 33(8):791-5. PubMed ID: 6776084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferrocins, new iron-containing peptide antibiotics produced by bacteria. Taxonomy, fermentation and biological activity.
    Katayama N; Nozaki Y; Okonogi K; Harada S; Ono H
    J Antibiot (Tokyo); 1993 Jan; 46(1):65-70. PubMed ID: 8436561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of hypeptin from Pseudomonas sp.
    Shoji J; Hinoo H; Hattori T; Hirooka K; Kimura Y; Yoshida T
    J Antibiot (Tokyo); 1989 Oct; 42(10):1460-4. PubMed ID: 2808133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The monosaccharide composition and serologic characteristics of lipopolysaccharides of nonfluorescent bacteria in the Pseudomonas fluorescens group].
    Zdorovenko GM; Veremeĭchenko SN; Zakharova IIa
    Mikrobiol Zh (1978); 1987; 49(5):13-8. PubMed ID: 3150500
    [No Abstract]   [Full Text] [Related]  

  • 15. [Search for new types of raw materials for antibacterial drugs].
    Sidorenko ML; Buzoleva LS
    Antibiot Khimioter; 2012; 57(5-6):7-10. PubMed ID: 23156038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudomonas fluorescens, a soil and water microbe. II. Antibiotic effects among Pseudomonas fluorescens strains].
    KLINGE K
    Arch Mikrobiol; 1959; 33():406-15. PubMed ID: 14409897
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonas fluorescens infections in clinical practice.
    Pappas G; Karavasilis V; Christou L; Tsianos EV
    Scand J Infect Dis; 2006; 38(1):68-70. PubMed ID: 16338843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study, using 3 methods, of the sensitivity to metronidazole and ornidazole of anaerobic or related bacteria].
    Gallusser A
    Ann Microbiol (Paris); 1983; 134B(2):307-21. PubMed ID: 6651124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satranidazole: experimental evaluation of activity against anaerobic bacteria in vitro and in animal models of anaerobic infection.
    Gowrishankar R; Phadke RP; Oza SD; Talwalker S
    J Antimicrob Chemother; 1985 Apr; 15(4):463-70. PubMed ID: 4008378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenelfamycins, a novel complex of elfamycin-type antibiotics. I. Discovery, taxonomy and fermentation.
    Jackson M; Karwowski JP; Theriault RJ; Maus ML; Kohl WL
    J Antibiot (Tokyo); 1988 Oct; 41(10):1293-9. PubMed ID: 3192489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.